nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alterations of routine blood tests in adult patients with soft tissue sarcomas: Relationships to cytokine serum levels and prognostic significance
|
Ruka, W. |
|
|
12 |
10 |
p. 1423-1432 |
artikel |
2 |
Alterations of routine blood tests in adult patients with soft tissue sarcomas: Relationships to cytokine serum levels and prognostic significance
|
W. Ruka |
|
2001 |
12 |
10 |
p. 1423-1432 10 p. |
artikel |
3 |
A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patients
|
Jassem, J. |
|
|
12 |
10 |
p. 1375-1381 |
artikel |
4 |
A multicenter randomized phase II study of oral vs. intravenousvinorelbine in advanced non-small-cell lung cancer patients
|
J. Jassem |
|
2001 |
12 |
10 |
p. 1375-1381 7 p. |
artikel |
5 |
A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic carcinoma
|
Halford, S. |
|
|
12 |
10 |
p. 1399-1402 |
artikel |
6 |
A phase II study evaluating the tolerability and efficacy of CAELYX(liposomal doxorubicin, Doxil) in the treatment of unresectablepancreatic carcinoma
|
S. Halford |
|
2001 |
12 |
10 |
p. 1399-1402 4 p. |
artikel |
7 |
A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma
|
Mackay, H.J. |
|
|
12 |
10 |
p. 1407-1410 |
artikel |
8 |
A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma
|
H. J. Mackay |
|
2001 |
12 |
10 |
p. 1407-1410 4 p. |
artikel |
9 |
A phase II study of gemcitabine in gallbladder carcinoma
|
Gallardo, J.O. |
|
|
12 |
10 |
p. 1403-1406 |
artikel |
10 |
A phase II study of gemcitabine in gallbladder carcinoma
|
J. O. Gallardo |
|
2001 |
12 |
10 |
p. 1403-1406 4 p. |
artikel |
11 |
Are smokers actually a bonus for the Social Security systems?
|
|
|
|
12 |
10 |
p. 1335-1338 |
artikel |
12 |
Book review
|
Biganzoli, L. |
|
|
12 |
10 |
p. 1496 |
artikel |
13 |
Book review
|
Escudier, B. |
|
|
12 |
10 |
p. 1497 |
artikel |
14 |
Book review
|
Ott, R. |
|
|
12 |
10 |
p. 1495 |
artikel |
15 |
Changed trends of cancer mortality in the elderly
|
Levi, F. |
|
|
12 |
10 |
p. 1467-1477 |
artikel |
16 |
Changed trends of cancer mortality in the elderly
|
F. Levi |
|
2001 |
12 |
10 |
p. 1467-1477 11 p. |
artikel |
17 |
Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group
|
Pectasides, D. |
|
|
12 |
10 |
p. 1417-1422 |
artikel |
18 |
Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group
|
D. Pectasides |
|
2001 |
12 |
10 |
p. 1417-1422 6 p. |
artikel |
19 |
Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease
|
Jagdev, S.P. |
|
|
12 |
10 |
p. 1433-1438 |
artikel |
20 |
Comparison of the effects of intravenous pamidronate and oralclodronate on symptoms and bone resorption in patients with metastaticbone disease
|
S. P. Jagdev |
|
2001 |
12 |
10 |
p. 1433-1438 6 p. |
artikel |
21 |
Contents of the next issue
|
|
|
|
12 |
10 |
p. iv |
artikel |
22 |
Copyright
|
|
|
|
12 |
10 |
p. ii |
artikel |
23 |
Corrigendum
|
|
|
2001 |
12 |
10 |
p. 1498-1498 1 p. |
artikel |
24 |
Corrigendum to: Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients
|
|
|
|
12 |
10 |
p. 1498 |
artikel |
25 |
Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin’s lymphoma
|
Machover, D. |
|
|
12 |
10 |
p. 1439-1443 |
artikel |
26 |
Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkins lymphoma
|
D. Machover |
|
2001 |
12 |
10 |
p. 1439-1443 5 p. |
artikel |
27 |
Diffuse large B-cell lymphoma with primary retroperitoneal presentation: Clinico-pathologic study of nine cases
|
Piled, S.A. |
|
|
12 |
10 |
p. 1445-1453 |
artikel |
28 |
Diffuse large B-cell lymphoma with primary retroperitonealpresentation: Clinico-pathologic study of nine cases
|
S. A. Pileri |
|
2001 |
12 |
10 |
p. 1445-1453 9 p. |
artikel |
29 |
Editorial Board
|
|
|
|
12 |
10 |
p. iii |
artikel |
30 |
Editorial comments on ‘Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study’
|
Bunn Jr, P.A. |
|
|
12 |
10 |
p. 1339-1340 |
artikel |
31 |
Editorial comments on Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study
|
P. A. Bunn Jr |
|
2001 |
12 |
10 |
p. 1339-1340 2 p. |
artikel |
32 |
E. E. Kim & D. J. Yang (eds): Targeted Molecular Imaging in Oncology
|
R. Ott |
|
2001 |
12 |
10 |
p. 1495-1495 1 p. |
artikel |
33 |
Experience in treatment of metastatic pulmonary carcinoid tumors
|
Granberg, D. |
|
|
12 |
10 |
p. 1383-1391 |
artikel |
34 |
Experience in treatment of metastatic pulmonary carcinoid tumors
|
D. Granberg |
|
2001 |
12 |
10 |
p. 1383-1391 9 p. |
artikel |
35 |
Fludarabine and mitoxantrone: Effective and well-tolerated salvage therapy in relapsed indolent lymphoproliferative disorders
|
Seymour, J.F. |
|
|
12 |
10 |
p. 1455-1460 |
artikel |
36 |
Fludarabine and mitoxantrone: Effective and well-tolerated salvagetherapy in relapsed indolent lymphoproliferative disorders
|
J. F. Seymour |
|
2001 |
12 |
10 |
p. 1455-1460 6 p. |
artikel |
37 |
Freedom under attack: Terrorists hit the USA
|
|
|
|
12 |
10 |
p. 1335-1338 |
artikel |
38 |
Freedom under attack: Terrorists hit the USA • Stopping the indiscriminate killers • US banned all human cloning after rejecting a plan to allow the procedure for research only, but... • Are smokers actually a bonus for the Social Security systems? • What is a correct difference in prices? • Will Novartis merge with Roche? • Mediterranean diet? Maybe, but go to Okinawa... • US patients bill of rights • Perhaps not everyone knows that...
|
|
|
2001 |
12 |
10 |
p. 1335-1338 4 p. |
artikel |
39 |
Identification of the B-cell tumor-specific molecular fingerprint using non-radiolabelled PCR consensus primers
|
Bendandi, M. |
|
|
12 |
10 |
p. 1479-1484 |
artikel |
40 |
Identification of the B-cell tumor-specific molecular fingerprint using non-radiolabelled PCR consensus primers
|
M. Bendandi |
|
2001 |
12 |
10 |
p. 1479-1484 6 p. |
artikel |
41 |
In this issue
|
|
|
|
12 |
10 |
p. iv |
artikel |
42 |
J. H. Mydlo (ed): Renal Cancer, Methods and Protocols
|
B. Escudier |
|
2001 |
12 |
10 |
p. 1497-1497 1 p. |
artikel |
43 |
Mediterranean diet? Maybe, but go to Oklnawa…
|
|
|
|
12 |
10 |
p. 1335-1338 |
artikel |
44 |
Metastatic malignant ameloblastoma responding to chemotherapy with paclitaxel and carboplatin
|
Grünwald, V. |
|
|
12 |
10 |
p. 1489-1491 |
artikel |
45 |
Metastatic malignant ameloblastoma responding to chemotherapy withpaclitaxel and carboplatin
|
V. Grünwald |
|
2001 |
12 |
10 |
p. 1489-1491 3 p. |
artikel |
46 |
Multicenter phase II–III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patients
|
Misset, J.-L. |
|
|
12 |
10 |
p. 1411-1415 |
artikel |
47 |
Multicenter phase IIIII study of oxaliplatin pluscyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaiveadvanced ovarian cancer patients
|
J.-L. Misset |
|
2001 |
12 |
10 |
p. 1411-1415 5 p. |
artikel |
48 |
Pathogenesis of malignant ascites: Starling’s law of capillary hemodynamics revisited
|
Tamsma, J.T. |
|
|
12 |
10 |
p. 1353-1357 |
artikel |
49 |
Pathogenesis of malignant ascites: Starlings law of capillary hemodynamics revisited
|
J. T. Tamsma |
|
2001 |
12 |
10 |
p. 1353-1357 5 p. |
artikel |
50 |
Perhaps not everyone knows that…
|
|
|
|
12 |
10 |
p. 1335-1338 |
artikel |
51 |
PET and PLAP in suspected testicular cancer relapse: Beware sarcoidosis
|
Karapetis, C.S. |
|
|
12 |
10 |
p. 1485-1488 |
artikel |
52 |
PET and PLAP in suspected testicular cancer relapse: Beware sarcoidosis
|
C. S. Karapetis |
|
2001 |
12 |
10 |
p. 1485-1488 4 p. |
artikel |
53 |
Prolonged neutropenia following anti CD20 therapy in a patient with relapsed follicular non-Hodgkin’s lymphoma and corrected with IVIG
|
Saikia, T.K. |
|
|
12 |
10 |
p. 1493-1494 |
artikel |
54 |
Prolonged neutropenia following anti CD20 therapy in a patient with relapsed follicular non-Hodgkins lymphoma and corrected with IVIG
|
T. K. Saikia |
|
2001 |
12 |
10 |
p. 1493-1494 2 p. |
artikel |
55 |
Quality of life in patients at risk of medullary thyroid carcinoma and followed by a comprehensive medical network: Trends for future evaluations
|
Freyer, G. |
|
|
12 |
10 |
p. 1461-1465 |
artikel |
56 |
Quality of life in patients at risk of medullary thyroid carcinomaand followed by a comprehensive medical network: Trends for futureevaluations
|
G. Freyer |
|
2001 |
12 |
10 |
p. 1461-1465 5 p. |
artikel |
57 |
Radon: A likely carcinogen at all exposures
|
Darby, S. |
|
|
12 |
10 |
p. 1341-1351 |
artikel |
58 |
Radon: A likely carcinogen at all exposures
|
S. Darby |
|
2001 |
12 |
10 |
p. 1341-1351 11 p. |
artikel |
59 |
Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study
|
Tjan-Heijnen, V.C.G. |
|
|
12 |
10 |
p. 1359-1368 |
artikel |
60 |
Reduction of chemotherapy-induced febrile leucopenia byprophylactic use of ciprofloxacin and roxithromycin in small-celllung cancer patients: An EORTC double-blind placebo-controlledphase III study
|
V. C. G. Tjan-Heijnen |
|
2001 |
12 |
10 |
p. 1359-1368 10 p. |
artikel |
61 |
S. A. Vasilev (ed): Perioperative and Supportive Care in Gynecologic Oncology: Evidence-Based Management
|
L. Biganzoli |
|
2001 |
12 |
10 |
p. 1496-1496 1 p. |
artikel |
62 |
Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin–gemcitabine–vinorelbine. A phase II study
|
Feliu, J. |
|
|
12 |
10 |
p. 1369-1374 |
artikel |
63 |
Sequential therapy in advanced non-small-cell lung cancer withweekly paclitaxel followed bycisplatingemcitabinevinorelbine. A phase II study
|
J. Feliu |
|
2001 |
12 |
10 |
p. 1369-1374 6 p. |
artikel |
64 |
Stopping the indiscriminate killers
|
|
|
|
12 |
10 |
p. 1335-1338 |
artikel |
65 |
Table of Contents
|
|
|
|
12 |
10 |
p. i-ii |
artikel |
66 |
US banned all human cloning after rejecting a plan to allow the procedure for research only,…
|
|
|
|
12 |
10 |
p. 1335-1338 |
artikel |
67 |
Use of gemcitabine (GEM) in advanced myelodysplastic syndromes
|
Di Mario, A. |
|
|
12 |
10 |
p. 1494 |
artikel |
68 |
Use of gemcitabine (GEM) in advanced myelodysplastic syndromes
|
A. Di Mario |
|
2001 |
12 |
10 |
p. 1494-1494 1 p. |
artikel |
69 |
US patients' bill of rights
|
|
|
|
12 |
10 |
p. 1335-1338 |
artikel |
70 |
Weekly docetaxel (Taxotere®) in patients with metastatic breast cancer
|
Stemmler, H.J. |
|
|
12 |
10 |
p. 1393-1398 |
artikel |
71 |
Weekly docetaxel (Taxotere®) in patients with metastatic breast cancer
|
H. J. Stemmler |
|
2001 |
12 |
10 |
p. 1393-1398 6 p. |
artikel |
72 |
What is a correct difference in prices?
|
|
|
|
12 |
10 |
p. 1335-1338 |
artikel |
73 |
Will Novartis merge with Roche?
|
|
|
|
12 |
10 |
p. 1335-1338 |
artikel |